Lisa Gora and Emma Pelkey, Members of the Firm, speak at the American Health Law Association (AHLA) Annual Meeting, which runs from June 24 to 26 in Washington, DC.

On Monday, June 24, Lisa co-presents “The World of Alternative Substances in Health Care: The Rise in Interest for Use of Cannabis, Ketamine, and Psychedelics (Psilocybin/MDMA) as Emerging Therapies by Practitioners.” Topics include:

  • How alternative substances are being looked at as emerging therapies in health care delivery, including the rise in use of ketamine and the rise in interest to use psilocybin, MDMDA and other psychedelic substances in health care delivery models
  • The federal Controlled Substances Act and that status of each drug as it relates to a corresponding schedule and the legal significance that plays
  • Corporate practice of medicine considerations, informed consent considerations, and other liabilities attendant to this practice area
  • Physician Involvement in the recommendation of cannabis, kratom, psilocybin or prescribing of ketamine off-label, which is becoming more prevalent; What are the licensure, malpractice and other issues and considerations to address with physicians, physician groups and health care facilities who/which are considering permitting such substances to be used, possessed, administered or stored on the facility premises
  • The clinical trials and clinical research conducted in the area of psychedelics and the role the findings and results from such trials and research play in the discussion regarding potential health plan coverage
  • Interest of private equity in emerging therapies and what type of alternative alignment strategies exist for physician practices to partner with private equity

Also on Monday, Emma co-presents “Nowhere to Go: Navigating Complex Patient Discharges.” Presenters discuss:

  • The scope of the problem and what populations are most impacted, including a discussion of the impact on behavioral health, elderly, and pediatric patients
  • How patients end up stuck in hospitals, including a discussion of EMTALA, safe discharge planning, civil commitment, and other causal factors
  • What barriers prevent discharges and the consequences of long lengths of stay
  • Statutory and regulatory compliance issues and oversight by federal and state agencies
  • Litigation and legislation aimed at removing barriers and creating long-term solutions. Practical, creative, and innovative strategies to reduce lengths of stay and address gaps in the continuum of care, including legal solutions

For more information and to register, please visit

Event Detail

Washington DC Marriott Marquis Hotel
Washington, DC

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.